News
Researchers say minimizing prenatal and early life exposure to CPF and other pesticides is likely important for optimal ...
Stem cells cryopreserved on the International Space Station for six months have successfully produced healthy mouse offspring ...
BioMADE’s investment in Iowa is expected to provide access to the technology infrastructure required to determine if a product is commercially viable.
Researchers say COMET’s architecture may also support other areas of nanotechnology where multi-component formulations are critical.
The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...
PepMLM generates binders to challenging therapeutic targets across cancer and neurological disease using protein sequence and ...
A new approach triggers meiosis, the cell division process responsible for producing egg and sperm, to aid future fertility treatments.
Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...
Made Scientific's new facility opening marks the completion of a $12 million initial investment in facility upgrades and equipment.
The two designed compounds, dubbed NG1 and DN1, effectively treated N. gonorrhoeae and S. aureus respectively in preclinical models.
Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.
The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results